Innocan Pharma Corp. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€0.31
Target price
23.01.22
€6.00
Performance (%)
33.11%
End price
24.01.22
€0.41
Summary
This prediction ended on 24.01.22 with a price of €0.41. The BUY prediction by Maxi_Scalibusa for Innocan Pharma Corp. saw massive gains of 33.11%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Innocan Pharma Corp. | - | - | - | - |
iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
According to Maxi_Scalibusa what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy mit Kursziel 6,0
In the thread Trading Innocan Pharma Corp.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten